Page 15 - Development Solutions News Today

Insightful Analysis of IQVIA's Position in the Evolving Healthcare Landscape

IQVIA (NYSE:IQV – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday. Several other analysts have also commented on the stock. Evercore ISI raised their price objective on shares of IQVIA from $255.00 to $265.00 and gave the stock a “market […]

IQVIA (NYSE:IQV – Get Free Report) had its price objective upped by analysts at Barclays from $260.00 to $265.00 in a research report issued on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the medical research company’s stock. Barclays‘s price objective would suggest a potential upside of 8.83% from the stock’s current […]

Bank Julius Baer & Co. Ltd Zurich lowered its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 26.5% during the third quarter, Holdings Channel.com reports. The fund owned 42,352 shares of the medical research company’s stock after selling 15,299 shares during the period. Bank Julius Baer & Co. Ltd Zurich’s holdings in IQVIA […]

The Warren County Planning Commission on Wednesday endorsed a developer’s proposal to put another hotel in the U.S. 340-522 North Corridor.

IQVIA beats Q4 2023 sales expectations, reporting $3.87 billion (3.5% Y/Y). Adjusted EPS of $2.84 exceeds guidance. IQV's 2023 performance and optimistic 2024 outlook.

Aviva PLC increased its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 5.3% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 515,611 shares of the medical research company’s stock after purchasing an additional 26,084 shares during the quarter. Aviva PLC’s holdings […]

IQVIA (NYSE:IQV – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share guidance of 10.950-11.250 for the period, compared to the consensus earnings per share estimate of 11.060. The company issued revenue guidance of $15.4 billion-$15.7 billion, compared to the consensus revenue estimate of $15.6 billion. IQVIA […]

UBS Group AG lowered its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 8.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 369,491 shares of the medical research company’s stock after selling 32,479 shares during the quarter. […]

UBS Group AG lowered its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 8.1% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 369,491 shares of the medical research company’s stock after selling 32,479 shares during the period. UBS Group AG’s holdings in IQVIA were worth $72,697,000 at the end […]